Strategic IP Acquisition / Licensing Opportunity: High-Yield Computational Algorithm

a proprietary, platform-agnostic weighted computational mathematical algorithm that is currently available for outright asset sale, licensing, or strategic acquisition with a trailing royalty structure. This mathematical computational engine functions as an advanced clinical decision-support plug-in designed to integrate seamlessly into existing digital software, NGS data pipelines, or array-CGH analysis workflows. It explicitly targets and resolves the high labor overhead associated with manual cytogenetic interpretation by automating the resolution of complex sex chromosome aneuploidies (SCAs) and multi-line mosaicism. Solving a Massive Clinical Bottleneck: Klinefelter syndrome and its variants are vastly undiagnosed or misdiagnosed in modern healthcare. Because standard diagnostic tools frequently fail to flag these non-linear chromosomal profiles early, individuals are routinely directed to the wrong clinical departments—undergoing inappropriate or ineffective treatments in psychiatry, oncology, or behavioral clinics for ADHD etc etc . This algorithm provides the precise mathematical framework required to catch these hidden variants early and accurately at the genomic level "warranting to send patient to Endochronology. Proven Performance Metric: In a recent clinical stress-test of a highly complex, multi-variant panel, the algorithm achieved a 100% diagnostic accuracy score. It successfully mapped, isolated, and differentiated a concurrent presentation of a mosaic father, a son with Klinefelter syndrome (47,XXY via Meiosis I non-disjunction), and a second son with Jacobs syndrome (47,XYY via Meiosis II non-disjunction)—a scenario that typically triggers extensive, manual human validation. Value Proposition for Your Ecosystem: Market Expansion: Opens up new diagnostic pipelines by capturing the vast, currently undetected population of clinical variants. Drastic Throughput Increase: Minimizes costly lab review hours for clinical geneticists by instantly automating complex edge cases. Agnostic Architecture: Formulated as a pure, lightweight mathematical engine that easily wraps into standard clinical software environments. Are you the correct contact to discuss potential portfolio alignment, or is there a specific member of your corporate development/technology acquisition team I should connect with? Sincerely, Franco Gentile CEO GENTILEX RESEARCH MONTREAL CANADA MOBILE 1 514 236 9875 admin@gentileXresearch.com